Supply chain consulting

Our client, a French manufacturer, noticed tension in their supply chain for certain primary materials (notably for their activities linked to the energy transition).

They asked for our help in carrying out an exhaustive analysis of their activities to identify all of their primary materials in order to analyze the possible risks to their supply and demand, and to understand their future internal needs in order to predict their potential exposure to shortages.

By taking into consideration the supply chain risks, the client’s needs, and the national ecosystem, we identified together all of the possible scenarios for limiting their risk exposure: reinforcing the local industrial sector, building a recycling sector, and even acquisition of players involved in local production sectors such as mineral extraction or refining.

We helped a large French region in defining a strategic roadmap aiming to roll out a policy encouraging usage of local products in the region’s school canteens.

Our project allowed the client to understand the supply chains of current agrifood products and to identify and characterize different opportunities for changing their supply routes to achieve their objectives.

Alcimed worked with a top pharmaceutical client to plan their commercial and logistics strategy for a novel targeted radionuclide.

Across six countries, Alcimed determined in which cancer centers or clinics were most patients treated for three major indications and their level of nuclear medicine capabilities. Alcimed built hypotheses based on the best available data (diagnosis or surgery numbers percenter, presence of a PET scanner or level of accreditation, county-level cancer incidence, etc.) and challenged them during interviews with nuclear medicine physicians, pharmacists, and other stakeholders.

Alcimed deployed an automated approach to map 4000 clinics and hospitals and identify the shortest freight time to potential manufacturing sites through road and air. The exploration of this interactive map with our client helped us validate that even with a limited shelf life, most major cancer sites would be able to receive the drug and treat patients.

This enabled our client to prioritize its commercial efforts in key cities to launch, and also determine a broader market-shaping strategy to overcome capability gaps in key countries.

Alcimed supported an industrial player involved in the production of green hydrogen in its strategy to diversify its supplies.

In the first stage, we mapped the key areas of expertise to be considered in order to identify potential new partners, by analysing industrial fields outside our client’s ecosystem with a view to establishing technology transfers. Secondly, our team identified and evaluated the industrial players capable of meeting our customer’s specifications.

By broadening the field of possibilities, this approach enabled our customer to identify new partner profiles capable of supporting them in their future developments.

We worked for a leading healthcare player facing the challenge to repurpose an existing antibiotic for neonatal sepsis to address antibiotic resistance.

Alcimed evaluated the demand for this antibiotic for neonatal sepsis due to bacterial infections, by analyzing the updated epidemiology across several geographies.

Our team then assessed the current supply capabilities of the antibiotic in the in-scope geographical areas to ultimately evaluate the risk of insufficient supply. Our project helped our client to understand the local constraints and better prepare for the operational challenges of their drug repurposing.

In anticipation of launching their first product, Alcimed helped a up and coming biotech company assess their manufacturing capabilities and logistics to identify potential bottlenecks in ramping up to full scale production.

Alcimed specifically surveyed the manufacturing plan for raw material sourcing to ensure sufficient supply of key ingredients from reliable partners.

The client was able to make key partnership and purchasing decisions to ensure that their manufacturing scale up had the correct contracts in place for both primary suppliers and secondary suppliers in order to smoothly transition in house from solely pre-clinical development to full scale manufacturer.

Alcimed supported one of its leading clients in aircraft production on the design of its future factory 4.0. The objective of our client was to gain competitiveness and to be one step ahead of its competitors in terms of expertise in assembly and testing.

To do this, Alcimed began by making an inventory of the client’s expertise. Then, our teams carried out a benchmark of the existing best practices in the assembly industry, analyzed their impact on our client’s KPIs, and analyzed their transferability for our client’s activities.

Finally, using all this information, our team held several workshops with our client to define their ideal smart factory and be able to challenge its solution providers.

We worked for a leader in the aerospace industry to evaluate possible business models and develop a business case for the deployment of CoBOTs (Collaborative Robots) in manufacturing sites.

We assisted our client in evaluating the possible uses of these robots working in the same areas as the teams, in analyzing the induced savings and in developing the roadmap for the deployment of these machines.

A complete business case was built to support the project with our client’s management committee.